Ginkgo Bioworks executive sells over $1,900 in stock By Investing.com
According to the latest filings with the U.S. Securities and Exchange Commission, an executive at Ginkgo Bioworks Holdings, Inc. (NYSE: Ginkgo), a leading biotech company, recently conducted a stock transaction. Stephen P. Quinn, the…
